News from CROI 2011

aidsmap news from CROI 2011

More than twice the risk of failure for patients starting on abacavir with low CD4s or high viral loads, compared with tenofovir

Grant P et al. Association of Baseline Viral Load, CD4 Count, and Week 4 Virologic Response with Virologic Failure in ACTG Study A5202. Eighteenth Conference on Retroviruses

Published
07 April 2011
By
Gus Cairns
‘Near perfect’ adherence in early stages of Partners PrEP study

Very high levels of adherence have been achieved in one of the ongoing randomised controlled trials of oral pre-exposure prophylaxis (PrEP), according to a poster presentation at

Published
29 March 2011
By
Gus Cairns
Gay men reduce their risk behaviour after HIV diagnosis, studies find, but disagree on how much by

The San Francisco study presented an apparently very different pattern of behaviour. This study counted the number of partners men had had in the previous three months.

Published
25 March 2011
By
Gus Cairns
High rate of HCV reinfection after treatment of acute infection in Amsterdam gay men

Lambers F et al. High incidence rate of HCV reinfection after treatment of acute HCV infection in HIV-infected MSM in Amsterdam. Eighteenth Conference on Retroviruses and Opportunistic

Published
10 March 2011
By
Keith Alcorn
Is treatment really reducing infections?

You can view the abstracts from this research on the official conference website: Abstract 1022 and the PDF of the poster: http://www.retroconference.org/2011/Abstracts/41808.htm Abstract 483: http://www.retroconference.org/2011/Abstracts/40183.htm Abstract 484: http://www.retroconference.org/2011/Abstracts/42134.htmAbstract 486:

Published
09 March 2011
By
Gus Cairns
At least one in six patients maintains a viral load over one hundred thousand

You can view the abstracts and posters from this research on the official conference website:Abstract 508: See the abstract here and poster here.Abstract 1024: See the abstract here and

Published
09 March 2011
By
Gus Cairns
Long-term HIV infection and poor inflammation control, not treatment, predicts risk of atherosclerosis

Desvarieux M et al. Carotid atherosclerosis is related to HIV duration and anti-inflammatory profile and not to ARV exposure: the CHIC controlled study. Eighteenth Conference on Retroviruses

Published
07 March 2011
By
Keith Alcorn
Optimising infant HIV treatment in resource-limited settings: when can nevirapine be used?

Infant treatment is complicated by exposure to single-dose nevirapine after delivery; infants who become infected despite prophylaxis have a high risk of acquiring nevirapine-resistant virus. Infant treatment with a nevirapine-containing

Published
07 March 2011
By
Carole Leach-Lemens
Six months of nevirapine prophylaxis for breastfeeding infants reduces transmission by 76% if mother not on ART

Extending the use of daily infant nevirapine to six months reduced the risk of breastfeeding mother-to-child transmission by a significant 76% in HIV-positive mothers with CD4 cell

Published
07 March 2011
By
Carole Leach-Lemens
Partners study expands our knowledge of HIV transmission risk

Having said this, viral load in semen and vaginal fluids probably influences the risk of transmission more than blood plasma viral load. Jared Baeten, also from UWS,

Published
03 March 2011
By
Gus Cairns
← First123Next →

The search for a cure

Zinc finger gene therapy produces HIV-resistant CD4 T-cells.

Read this news story >

Subscribe now

Email bulletins from NAM